Strides Pharma US unit gets 4 observations after FDA scan, says no supply impact
Published on: Dec. 24, 2025, 7:34 p.m. | Source: CNBC TV18
Strides Pharma Science Ltd's Chestnut Ridge facility received four procedural FDA observations, with no impact on supply. Shares of Strides Pharma Science Ltd ended lower on Wednesday, December 24, by 3.59% at ₹936 on the NSE.
